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A B ST R AC T  
 
Aim: In this study we aimed to compare the 25(OH) vitamin D level of obese patients and the serum 
25(OH) vitamin D level of healthy individuals who have normal weight; and also to evaluate the 
relation between 25(OH) vitamin D level and body mass index (BMI), waist circumference, hip 
circumference, body fat ratio. 
Methods: Among the patients who went into Okmeydani Training and Research Hospital Internal 
Medicine polyclinic and the patients hospitalized at the Internal Medicine clinic between the dates 
December 2012 - May 2013 and whose ages range between 18 and 70; total 105 individuals took part 
in the study. 62 individuals whose BMI is ≥30 formed the patient group, while 43 individuals whose 
BMI is between 18, 5 and 25 formed control group. Vitamin D level of the patient group and control 
group was measured. The data obtained was statistically analyzed. 
Results: The weight, BMI, waist circumference, hip circumference, body fat ratios of the patients in 
the case group were significantly higher than the ones in the control group (p<0.05). The 25 (OH) 
vitamin D level of the patients in the case group was significantly less than the ones in control group 
(p=0.03). There was statistically significant negative correlation between 25 (OH) vitamin D value and 
weight (r=-0.26 p=0.01), waist circumference (r=-0.23 p=0.02), and BMI (r=-0.26 p=0.01). 
Conclusion: Physicians should consider in treatment of vitamin D deficiency that, serum vitamin D 
levels are higher in obese compared to lean subjects and correlated negatively with BMI, weight and 
waist circumference. 
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Introduction 
Obesity is one of the most important health 
problems in today’s world. Since it’s frequency 
increasing year by year, many government 
developed anti-obesity programs to decrease 
obesity rates. Metabolic syndrome, the most 
important complication of obesity, is the main 
cause type 2 diabetes mellitus and 
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cardiovascular diseases, which cause enormous 
morbidity and mortality worldwide [1].  
Recent evidence suggest that vitamin D may be 
associated with many bodily functions besides 
its action in calcium and bone metabolism. One 
of these conditions is obesity. Interestingly, 
serum vitamin D levels are decreased in 
patients with metabolic syndrome or obesity.  
In present study, we aimed to compare serum 
vitamin D levels of lean and obese subjects and 
to observe association between vitamin D and 
body mass index (BMI), waist circumference 
(WC), hip circumference (HC), body fat 
proportion. 
 
Methods 
Serum vitamin D levels and other 
anthropometric measurements obtained from 
patients whom presented to internal medicine 
outpatient clinics of our institution between 
December 2012 and May 2013. Informed 
consent from participants and ethical approval 
from local ethics committee were obtained 
before initiation of the study. Study cohort 
grouped into obese and control groups 
according to the classification of world health 
organization 1998 criteria [2]. According to 
these criteria, a BMI equal to or greater than 
30kg/m2 were classified as obese, and lower 
than 30 were classified as control groups.  
Exclusion criteria were as follows: chronic 
kidney disease (serum creatinine >1,4mg/dl), 
chronic liver failure, subjects receiving vitamin 
D supplements, a history of medications that 
may interfere with calcium and vitamin D 
metabolism.  
Body weight was measured with a CPS -106 
model of Conti weighbridge (Conti, 2012, 
China). Height, WC and HC were measured 
with a measure of Hobby (Hobby, 2012, 
Germany). Body fat proportion was calculated 
by bio-impedance assay with BF-306 model 
device of Omron (Omron, 2009, United 
Kingdom). Assay results were classified as low, 
normal, high or too high. Serum vitamin D 
assay was done with high performance liquid 
chromatography method. Lower than 20 ng/ml 
classified as insufficient, 20 to 30 ng/ml 
classified as low and higher than 30 mg/ml 
classified as normal.  
 
Statistical Analysis 
Statistical analyses were conducted with SPSS 
software (SPSS 15.0 for Windows, IBM Co., 
Chicago, Il, USA). Normal or not distribution 
of the variables among study groups were 
analyzed with Kolmogorov-Smirnov test. 
Variables with normal distribution were 
compared by t test and variables without normal 
distribution were conducted with Mann 
Whitney U test. Chi-square test used in 
comparison of categorical variables.  
 
Results 
Sixty-two patients (40 women and 22 men) 
between 18-70 years of age and with BMI ≥30 
kg/m2 in obesity group, and 43 controls (26 
women and 17 men) with BMI between 18.5 
and 25 kg/m2 in control group were enrolled in 
the study. There was no statistically significant 
difference between the study and control groups 
in terms of age and gender distribution 
(p=0.095, p=0.673, respectively) (Table 1). 
In the study group, body weight, BMI, waist 
circumference, hip circumference, body fat 
ratio were significantly higher than control 
group (p <0.001, p <0.001, p <0.001, p <0.001, 
respectively) (Table 2). The patients in the 
study group were significantly shorter than the 
control group (p = 0.034). 
Serum 25 (OH) vitamin D levels of study and 
control   groups    were    17±8,62  ng/ml     and  
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Values: Mean±SD. *t test/chi-square test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20,76±8,27 ng/ml, respectively. The difference 
was statistically significant (Table 3). 
25 OH-D levels are significantly lower in 
women than in men. The mean 25 (OH) vitamin 
D in women was 17,13 ± 7,94 ng / ml while in 
men it was 20,94 ± 9,34 ng / ml. 
There was a significant negative correlation 
between the 25 (OH)   vitamin D level and body  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
weight, waist circumference, BMI, and alkaline 
phosphatase levels. There was no significant 
correlation between 25 (OH)   vitamin D levels 
and age, height, body fat ratio, hip 
circumference, phosphorus, albumin, PTH, 
glucose, AST, ALT, creatinine, urea, uric acid, 
HbA1c, 24 hour urine calcium value (Table 4). 
There was a negative correlation   between  the  
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alkaline phosphatase and 25 (OH) vitamin D 
when analyzed by Pearson’s correlation test, 
and this correlation was statistically significant 
(r = -0.232, p = 0.017). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pearson correlation. 
 
Discussion 
The emergence of relationships between 
vitamin D and the components of the metabolic 
syndrome, the most common and deadly 
complication of obesity, a  century-old disease,  
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and even type 1 diabetes, suggests that Vitamin 
D is a hormone that needs further investigation. 
In this context, we also investigated the 
relationship between vitamin D level and its 
association with BMI, waist circumference, hip 
circumference, body weight and body fat ratio 
in obese patients. 
The fact that the mean serum vitamin D level is 
normally low in a total of 105 individuals 
consisting of study and control groups, suggests 
that vitamin D deficiency may be extremely 
common in our society. The prevalence of low 
vitamin D levels can be attributed to the fact 
that the patients in the study were participated 
in the coldest season of Istanbul between 
December 2012 and May 2013. Of course 
vitamin D levels reflect not only sunlight but 
also environmental and personal factors. These 
include the fact that Istanbul's working 
environment is usually indoor; such as offices 
and factory, and population consume less 
vitamin D-rich nutrients such as fish and milk, 
as the industry has developed. In a study 
conducted to observe geographical and climatic 
characteristics in Turkish immigrants living in 
Western countries revealed that 25 (OH) 
vitamin D deficiency was extremely high. This 
is explained by the fact that obesity indoor 
dressing, low exposure to sunlight and dark 
skinnedness were high in this group [3]. In 
studies conducted in relation to indoor clothing 
in Turkish women, 25 (OH) vitamin D 
deficiency was found to be prominent 
especially in women dressed in such a way as 
to cover their arms [4]. In our study, 25 (OH) 
vitamin D levels were significantly lower in 
patients with high BMI than those with normal 
BMI, and negative correlation between BMI 
and vitamin D was found. The negative 
association between BMI and 25 (OH) vitamin 
D level has been previously reported in many 
studies [5-11]. Several arguments have been put 
forward to explain the reason for the low 
vitamin D in obese people. These obese people 
are less mobile and are exposed to less 
ultraviolet (UV) light as they go out less, 
consume less vitamin D-containing foods, have 
vitamin D spread in fat tissue, and increase the 
efficiency of 1-α hydroxylase enzyme in the 
kidney sortable [9]. Four studies in recent years 
have suggested that 1,25 (OH)2 vitamin D, 
which is increased in obesity, promotes 
lipogenesis and prevents 25 (OH) vitamin D 
formation by negative feedback [12-15].  
However, the number of samples of these four 
studies is very low (between 10 and 16); the 
vitamin D assay (protein binding assay) used in 
these studies is less sensitive and is not 
currently used. 
In non-obese, the effects of vitamin D were also 
wondered and a study was conducted on 180 
non-obese female and 201 male Lebanese 
university students. Although the participants 
had normal body weight, 25 (OH) vitamin D 
was found to be negatively associated with BMI 
[16]. In our study, there was no significant 
relationship between BMI and 25 (OH) vitamin 
D in the group with normal BMI. 
In a study of two hundred obese patients, a more 
significant decrease in PTH levels was 
observed in the group given vitamin D [17]. In 
our study, there was no significant correlation 
between 25 (OH) vitamin D and PTH levels. 
In a study of 3262 cases, vitamin D deficiency 
was found in 69.2% of cases [18]. In our study, 
vitamin D deficiency was found to be 60% in 
all cases, 62.9% in the obese group and 55.8% 
in the control group. However, our study was 
not designed to observe the rate of vitamin D 
deficiency in general population.  
In a study of 248 obese patients in which the 
relationship between body fat ratio and vitamin 
D was studied, a significant relationship was 
found between D low vitamin D and body fat 
Erkus et al.  Exp Biomed Res 2018;1(3):82-89  
  
 
87 
 
mass [19]. In our study, the body fat percentage 
measured by bioelectrical impedance method 
was significantly higher in the case group than 
the control group. However, there was no 
significant correlation between body fat 
percentage and vitamin D in the whole 
population. 
In a study of 528 obese patients with metabolic 
syndrome in which the relationship between 
waist circumference and 25 (OH) vitamin D 
levels was examined, a significant negative 
correlation was found between waist 
circumference and 25 (OH) vitamin D. At the 
same time, there was an independent negative 
correlation between obesity and waist 
circumference and 25 (OH) vitamin D [19]. In 
a study of women with 102 metabolic syndrome 
and 18 women with premenopausal age, the 
waist circumference was higher in the group 
with vitamin D deficiency  [20]. In our study, 
waist circumference was significantly higher in 
the study group than in the control group. 
Overall, there was a significant negative 
correlation between 25 (OH) vitamin D and 
waist circumference. However, there was no 
significant correlation between 25 (OH) 
vitamin D and the hip circumference in present 
study.  
In a study of a type 2 diabetic, 60 control cases, 
25 (OH) vitamin D, significantly elevated 
HbA1c, waist circumference and hip 
circumference were detected in patients in the 
study. In this study, a significant negative 
correlation was detected in the correlation 
analysis with 25 (OH) vitamin D and HbA1c  
[21]. Another study in a 50-DM patient did not 
find a significant relationship between vitamin 
D levels and HbA1c  [22]. In our study, no 
significant relationship was found between 
HbA1c and 25 (OH) vitamin D in relation to 
each other. In addition, there was no significant 
correlation between glucose and 25 (OH) 
vitamin D in our study. Other studies are 
diabetic studies. Our patients did not have 
diabetes. In a study evaluating 110 patients in 
2012, no correlation was found between 
alkaline phosphatase and 25 (OH) vitamin D in 
the correlation analysis performed in all 
patients [23]. In our study, there was a negative 
correlation between alkaline phosphatase 
(ALP) and 25 (OH) vitamin D when analyzed 
by Pearson’s correlation test, and this 
relationship was statistically significant.  
As a result, there was a negative correlation 
between BMI, body weight, ALP, waist 
circumference and 25 (OH) Vitamin-D in our 
study. No significant correlation was found 
between 25 (OH) vitamin D and age, body fat 
ratio, HbA1c and hip circumference. 25 (OH) 
vitamin D levels are lower in obese patients 
than in patients with normal VKI, suggesting 
that obesity may play a role in the pathogenesis 
of vitamin D deficiency. In addition to adjusting 
the balance of caloric intake and physical 
activity, obesity should be emphasized as well 
as the importance of using sunlight to prevent 
obesity.  
In conclusion, we believe that measuring 
vitamin D levels in obese patients would be 
beneficial. There is a need for long-term 
prospective observational studies with larger 
population in this regard supporting our results 
are needed. 
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